Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits ...
Donanemab (Kisunla), a new drug to treat Alzheimer's disease, was approved by the U.S. Food and Drug Administration on ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...
There’s no cure for Alzheimer’s disease, but in the past few years, researchers have found treatments that seem to stop some ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
I’m so excited that we have something that actually possibly could lead to a cure. There is no cure yet. But we’re really ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...